<SEC-DOCUMENT>0001104659-13-030971.txt : 20130520
<SEC-HEADER>0001104659-13-030971.hdr.sgml : 20130520
<ACCEPTANCE-DATETIME>20130419172400
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001104659-13-030971
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20130419

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>


<html>
<head>

  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="73%" valign="top" style="padding:0in 0in 0in 0in;width:73.34%;">
<p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman"><img width="177" height="77" src="g96284bci001.jpg"></font></p>    </td>
<td width="26%" valign="top" style="padding:0in 0in 0in 0in;width:26.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cyclacel   Pharmaceuticals, Inc.</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">April&nbsp;19, 2013</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">VIA EDGAR</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Securities and Exchange Commission</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Division of Corporation Finance</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100 F Street, N.E.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Washington, D.C. 20549</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attention:&#160; Austin Stephenson,&nbsp;Esq.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.84%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Re:</font></b></p>    </td>
<td width="93%" valign="top" style="padding:0in 0in 0in 0in;width:93.16%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Cyclacel   Pharmaceuticals,&nbsp;Inc.</font></b></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.84%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="93%" valign="top" style="padding:0in 0in 0in 0in;width:93.16%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Registration   Statement on Form&nbsp;S-3</font></b></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.84%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="93%" valign="top" style="padding:0in 0in 0in 0in;width:93.16%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Initially   Filed on April&nbsp;8, 2013, as amended on April&nbsp;18, 2013</font></b></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="93%" valign="top" style="padding:0in 0in 0in 0in;width:93.16%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">File   No.&nbsp;333-187801</font></b></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dear Mr.&nbsp;Stephenson:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">With respect to the above-referenced Registration Statement on Form&nbsp;S-3 (the &#147;<b>Registration Statement</b>&#148;), and pursuant to Rule&nbsp;461 of Regulation C promulgated under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of Cyclacel Pharmaceuticals,&nbsp;Inc. (the &#147;<b>Company</b>&#148;), that the Securities and Exchange Commission (the &#147;<b>Commission</b>&#148;) accelerate the effective date of the Registration Statement to Monday, April&nbsp;22, 2013 at 4:00&nbsp;p.m., or as soon as practicable thereafter.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In connection with the foregoing request, the Company acknowledges the following:</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The cooperation of the staff in meeting the timetable described above is very much appreciated.&#160; Please call Joel I. Papernik of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (212) 692-6774 with any comments or questions regarding the Registration Statement.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:37.05pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very   truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   Paul McBarron</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Paul   McBarron</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Executive   Vice President, Finance,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief   Financial Officer and</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief   Operating Officer</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt 253.65pt;text-indent:-253.65pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">x</font><font size="2" style="font-size:10.0pt;">&nbsp;200 Connell Drive #1500, Berkeley Heights, New Jersey 07922, USA Tel +1 (908) 517 7330 Fax +1 (866) 271 3466</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="2" style="font-size:10.0pt;">&nbsp;</font><font size="1" style="font-size:6.0pt;">  </font><font size="2" style="font-size:10.0pt;">Dundee Technopole, 1 James Lindsay Place, Dundee, DD1 5JJ, UK Tel +44 1382 206 062 Fax +44 1382 206 067</font></p>
<p align="center" style="margin:0in 0in .0001pt 253.65pt;text-align:center;text-indent:-253.65pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">www.cyclacel.com &#150; info@cyclacel.com</font></p>
<p style="margin:0in 0in .0001pt 253.65pt;text-indent:-253.65pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105589\13-9628-4\task5975498\9628-4-bc.htm',USER='105589',CD='Apr 20 02:13 2013' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g96284bci001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g96284bci001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`!-`+$#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:BBF331V
M\32RN$1!EF)X`H#8?4%Q?6MH,W%Q'%_O-BN.U3Q?>:A<?8M"B<@\>8%RQ^GH
M*R9]"O`3+JVIPV[MR5DDW-^0KMAA/^?CMY=3SJF.W5*-_/H=Y_PD6C9Q_:5O
MG_?%7+>[M[I=UO,DH]5;->7-IVE=(]:0M[Q$"GIIFIV@^U:?="=4YW6\F2/P
MK5X.G;25O4PCCZM_>BGZ,]4HKB="\;L9%M=5`!)P)@,<^XKM0<C(KBJT9TG:
M1Z5&O"M&\&+11161L%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!7%:_=
MW/B+65T*P;$,9S,XZ9[Y]A73:U?#3M*N+G/S)&2ON<5REBLFB>$GOU!.H:DP
M5#W^8\?U-=F'C;W^NR]?^`<&+G?]WTW?IV^8A=K*8Z'X;C#S8_TB[/4'OSVK
M-EM--BN#&[7.K7F?G\H_(#]>IK7&FO:HFB6\WD[H_/U*Z[@?W<TR-A'"HLY'
MT^Q?B&.&/=<7/^U["NN,K;?\/Z_HET."4&]_^`O)+;U;ZF7+9[$W2>&9D0CJ
MLC9%0V]K!+)YFCW<L%VG(MY>&/L#W^E:\EI);YF>+6K4=?/W^9CW*U)#90RN
MEUK#VY3>GV2^B<(9W)^5"/4XJG548W;_`*_KSN1&@Y2LE^GY6_*PS3]-MM:C
M^U:K;_9;I'VJ`1']H(YZ'O\`2H/A]XQ\1>(-?U*QU;31;V]L/D(C*[#G&TD]
M>*?%X>O?';6FI>)K.?2+G2[MO)BADXE3@@GTY'6N^"@$D``GK[UY=6JZC\CV
MJ-&-):;]7W%HHHK(W"BBB@`HHHH`****`"BBB@`HHHH`**R]6UD:7)$GDM(9
M"!D#IDX'_P!>K&EZ@NJ6"7:1/$&+#:XP1@D?TH`N4444`<SXY).DQ(#P\NT_
MB#4VHP*VI:#;;<QHS-C_`'4XJ7Q;:-<Z))(@RUOF0#N<"FWTRE-(U,<QI(H8
MCL'7&?SQ79!^Y&WG^1P5(_O)M_W?N3U*`B-XEX&./MNIB&0CKL7M^E;.D01L
M)+_8/,G8A3C[J*<!1Z#BJK6[0S7<2#+Q7"WD:C^('[P_,'\Q6A8RQ(@B4C8V
M6B/9E/./J*FI*\=/Z_K0JE!*>O\`7]:_>69G,<>51G)(``'KZ^U4+;2M\OVB
M]P[,J?Z,,-#$RDG<@(X//6M(D`9)P*%8.H93D'H:Y3M%JAK>K0Z'HMWJEP"8
MK6(R$#J?0?G5^LCQ7I$FO^%M1TJ)PDES"51CTSU'ZB@#F=%T'6?%6GQ:UKVM
MWUJUTOF0V5E)Y20H?NY[DXI?$>GZQX7LM/UK3]2OM032V/VR&:3<9X">21W9
M:7PSX]TNQT>#2_$<XTG4[%!#-%<@J&*C&Y3T(.*Z^PO['6].%U9RI<VDP(#`
M?*XZ'K0!R6JZU-XLUK3M$\/WCI;!4O-0NH6P5B/*Q@^K5!;W.K>/=;U"*UU.
M;3-"TZ8V^;;Y9KB0?>^;LHJ3X1VEO;^';YX8E1FU&96(ZD*V%'X"J6A:HGP^
MUO5-'U\/!8WET]W9WQ4F(AN2K$="*`-?5-%F\,^$]=N;76=1G)LG,8N)M_E,
M`?F4]0:VO",\MSX0TB>>1I99+.-G=CDL2HR36+XA\3:+KW@WQ!%I6H17;0V$
MC2>4<A<J<<_A47@KQGX;_P"$<T73/[9M?MGV:*+R=WS;]H&WZYH`G\>WUY,V
MF^&]*N7MK[59\--&<-%"O+M_2K/@35)[OP\]IJ$K/?Z7,]K=,YR25/#?B,5@
M6L>M>(_&^I^(-%N+*.&QSIT)ND9P<<NRXZ<\5'IZZGX:^(SPZU-;/%XFB(W6
MRE4$R#`X/<C^=`%G2O[8^(4USJ4FJW.F:+',T-M;V;!7FVG!9F^O:I?%&FW7
MA7P%K<MIK6H3L45HFGEW-#SSM;KSFJ/A+7;;P(EQX8\1[K`0SR26MVZGRIXV
M;(^;L:N^./$.DZ]\.M=;2KV.[6"-1(T><`D\<_A0!-X;T&S673[X>*]0NI]B
MR&W>]#*Y*\@KZ<U+X0OKNY\8^+8)[F26*WNHUA1FR(P5.0/2LWPFWPWBN--;
M39-.&K&-0FQSOWE>1]>M5]`\2Z+H/CKQ>NK:E!9F6[C,8E;&["G./S%`'I+Q
M1R8WHK8Z9%.``&`,"J^GZC9ZK9)>V%PEQ;R9V2(<@U9H`****`&NBR1LCC*L
M""/45@Z9`JQ77AV\!98P3"3_`!1'ICW!KH*HZGIYO$26&3R;J$[HI!V]C[&M
M(2MH_P"F8U87M)=/Q78I0K,[+;32"/4;4'RI3TF3U]_?WJ174DQL5MI"<M!+
M]PGU4_X4U+F"_"VNI1?9;Q?NC..?5&J9HK^$;'2.^C'0M\K_`.!K1^?]>ADN
MZU_KKUO_`$QS1/MYBA4`?>>0D?E2V]UF01Q.UTQ/S.HPB#V_^M4/&?ET9]WN
M5Q_.GB#4+E=DC1V<'=8N6(^O:E96U*3=]/Z_)&D"#T.:6LZ"]M(IDL;)3*0<
M.4Y">I)]:T:R<6C>,E):%>XL+.[(-S:03$=#)&&Q^=2QQQPH(XD5$'15&`*?
M14E$<-O#;J4@B2)22Q"*`"3U/%$T$-Q&8YXDE0]5=0P_(U)10!7CT^RAB>&*
MS@CC<8=%C`##W'>HDT;2XI%DCTVT1U.598%!!_*KM%`$<-O#;H4@B2)22Q"*
M`"3U/%)+;03O&\T,<C1G<A902I]1Z5+10!%/;072;+B".9/[LB!A^M,73[);
M=K=;2`0M]Z,1C:?J*L44`4XM(TR&598M.M8Y%.5985!!]CBB72--GE:6;3[6
M21CEG>%23^.*N44`1PP0VT0B@B2*->B(H4#\!4E%%`!1110`4444`075E;WL
M?EW$2R#MGJ/H:H_V=?6HQ97[%!TCF&X#\>M:M%6IM:$2IQD[]3%#>)"^TI9A
M<_?W'./I4G]DW5T!_:%_(Z]XHOD4_E6M15>U?1)$*BOM-OYD5O;06D0B@B6-
M!V45+1163=]S5))604444#"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#
"_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
